Mammalian protein-protein interaction trap (MAPPIT) analysis of STAT5, CIS, and SOCS2 interactions with the growth hormone receptor.

Binding of GH to its receptor induces rapid phosphorylation of conserved tyrosine motifs that function as recruitment sites for downstream signaling molecules. Using mammalian protein-protein interaction trap (MAPPIT), a mammalian two-hybrid method, we mapped the binding sites in the GH receptor for signal transducer and activator of transcription 5 (STAT5) a and b and for the negative regulators of cytokine signaling cytokine-inducible Src-homology 2 (SH2)-containing protein (CIS) and suppressor of cytokine signaling 2 (SOCS2). Y534, Y566, and Y627 are the major recruitment sites for STAT5. A non-overlapping recruitment pattern is observed for SOCS2 and CIS with positions Y487 and Y595 as major binding sites, ruling out SOCS-mediated inhibition of STAT5 activation by competition for shared binding sites. More detailed analysis revealed that CIS binding to the Y595, but not to the Y487 motif, depends on both its SH2 domain and the C-terminal part of its SOCS box, with a critical role for the CIS Y253 residue. This functional divergence of the two CIS/SOCS2 recruitment sites is also observed upon substitution of the Y+1 residue by leucine, turning the Y487, but not the Y595 motif into a functional STAT5 recruitment site.

[1]  J. Tavernier,et al.  Functional Cross-modulation between SOCS Proteins Can Stimulate Cytokine Signaling* , 2006, Journal of Biological Chemistry.

[2]  S. Hubbard,et al.  Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling-3. , 2006, Structure.

[3]  Karl H. Clodfelter,et al.  Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. , 2006, Molecular endocrinology.

[4]  J. Tavernier,et al.  A complex interaction pattern of CIS and SOCS2 with the leptin receptor , 2006, Journal of Cell Science.

[5]  Stefan Knapp,et al.  Crystal structure of the SOCS2–elongin C–elongin B complex defines a prototypical SOCS box ubiquitin ligase , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Norton,et al.  The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability. , 2006, Molecular cell.

[7]  G. Norstedt,et al.  Negative regulation of growth hormone receptor signaling. , 2006, Molecular endocrinology.

[8]  S. Becker,et al.  Structure of the Unphosphorylated STAT5a Dimer* , 2005, Journal of Biological Chemistry.

[9]  D. Waxman,et al.  Role of the Cytokine-induced SH2 Domain-containing Protein CIS in Growth Hormone Receptor Internalization* , 2005, Journal of Biological Chemistry.

[10]  I. Lemmens,et al.  A systematic scan of interactions with tyrosine motifs in the erythropoietin receptor using a mammalian 2-hybrid approach. , 2005, Blood.

[11]  B. Blom,et al.  STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression , 2005, Nature Immunology.

[12]  Claes Ohlsson,et al.  SOCS2 negatively regulates growth hormone action in vitro and in vivo. , 2005, The Journal of clinical investigation.

[13]  R. Teasdale,et al.  In Vivo Analysis of Growth Hormone Receptor Signaling Domains and Their Associated Transcripts , 2005, Molecular and Cellular Biology.

[14]  Keiichi I Nakayama,et al.  VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. , 2004, Genes & development.

[15]  B. Little,et al.  Growth hormone insensitivity associated with a STAT5b mutation. , 2003, The New England journal of medicine.

[16]  Jan Tavernier,et al.  Heteromeric MAPPIT: a novel strategy to study modification-dependent protein-protein interactions in mammalian cells. , 2003, Nucleic acids research.

[17]  W. Alexander,et al.  Biological Evidence That SOCS-2 Can Act Either as an Enhancer or Suppressor of Growth Hormone Signaling* , 2002, The Journal of Biological Chemistry.

[18]  S. Asa,et al.  Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). , 2002, Molecular endocrinology.

[19]  Jan Tavernier,et al.  Design and application of a cytokine-receptor-based interaction trap , 2001, Nature Cell Biology.

[20]  J. Turkson,et al.  Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell Transformation* , 2001, The Journal of Biological Chemistry.

[21]  T. Zhu,et al.  Signal transduction via the growth hormone receptor. , 2001, Cellular signalling.

[22]  D. Waxman,et al.  Role of the Cytokine-inducible SH2 Protein CIS in Desensitization of STAT5b Signaling by Continuous Growth Hormone* , 2000, The Journal of Biological Chemistry.

[23]  J. Tavernier,et al.  Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor , 2000, FEBS letters.

[24]  J. Kopchick,et al.  Growth hormone (GH), GH receptor, and signal transduction. , 2000, Molecular genetics and metabolism.

[25]  W. Alexander,et al.  Gigantism in mice lacking suppressor of cytokine signalling-2 , 2000, Nature.

[26]  D. Waxman,et al.  SOCS/CIS Protein Inhibition of Growth Hormone-stimulated STAT5 Signaling by Multiple Mechanisms* , 1999, The Journal of Biological Chemistry.

[27]  M. Kubo,et al.  Suppression of STAT5 Functions in Liver, Mammary Glands, and T Cells in Cytokine-Inducible SH2-Containing Protein 1 Transgenic Mice , 1999, Molecular and Cellular Biology.

[28]  J. G. Zhang,et al.  The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Alexander,et al.  Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL‐6 signal transduction , 1999, The EMBO journal.

[30]  T. Naka,et al.  Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Becker,et al.  Three-dimensional structure of the Stat3β homodimer bound to DNA , 1998, Nature.

[32]  L. Mathews,et al.  Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling , 1997, Molecular and cellular biology.

[33]  J. Schwartz,et al.  Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B. , 1997, Endocrinology.

[34]  R. Snell,et al.  Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[36]  P. Heinrich,et al.  Comparative study on the phosphotyrosine motifs of different cytokine receptors involved in STAT5 activation , 1996, FEBS letters.

[37]  P. Kelly,et al.  Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor. , 1996, Molecular endocrinology.

[38]  J. Nielsen,et al.  Identification of Tyrosine Residues in the Intracellular Domain of the Growth Hormone Receptor Required for Transcriptional Signaling and Stat5 Activation (*) , 1996, The Journal of Biological Chemistry.

[39]  D. Meyer,et al.  The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. , 1996, Molecular endocrinology.

[40]  William I. Wood,et al.  Growth hormone receptor and serum binding protein: purification, cloning and expression , 1987, Nature.

[41]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[42]  J. Tavernier,et al.  The C-terminus of CIS defines its interaction pattern. , 2007, The Biochemical journal.

[43]  J. Kopchick,et al.  Growth hormone (GH) receptor knockout mice reveal actions of GH in lung development , 2006, Proteomics.

[44]  A. Yoshimura,et al.  CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation. , 2003, Journal of biochemistry.

[45]  J. Kopchick,et al.  Transgenic models of growth hormone action. , 1999, Annual review of nutrition.